The challenge of traditional Chinese medicines for allopathic practitioners

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H1967-9. doi: 10.1152/ajpheart.00944.2009. Epub 2009 Oct 23.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / therapeutic use
  • Aortic Diseases / complications
  • Aortic Diseases / drug therapy*
  • Aortic Diseases / metabolism
  • Aortic Diseases / pathology
  • Aortic Rupture / etiology
  • Aortic Rupture / metabolism
  • Aortic Rupture / pathology
  • Aortic Rupture / prevention & control*
  • Atherosclerosis / complications
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Biomarkers / metabolism
  • Cardiovascular Agents / chemistry
  • Cardiovascular Agents / therapeutic use*
  • Complementary Therapies*
  • Disease Progression
  • Drugs, Chinese Herbal / chemistry
  • Drugs, Chinese Herbal / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Inflammation Mediators / metabolism
  • Lipids / blood
  • Simvastatin / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Biomarkers
  • Cardiovascular Agents
  • Drugs, Chinese Herbal
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Inflammation Mediators
  • Lipids
  • tongxinluo
  • Simvastatin